
OSR Holdings, Inc. — Investor Relations & Filings
OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-02 | English | |
| PROXY STATEMENT | 2026-05-26 | English | |
| 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | |
| 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47937235 | CURRENT REPORT | 2026-06-02 | English | ||
| 47073266 | PROXY STATEMENT | 2026-05-26 | English | ||
| 45603271 | 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | ||
| 42032938 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | ||
| 39151751 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | ||
| 35420934 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English | ||
| 33910620 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-09 | English | ||
| 33256646 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-03 | English | ||
| 33191238 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-02 | English | ||
| 32013135 | 8-K Filing | 2026-01-27 | English | ||
| 13362203 | CURRENT REPORT | 2026-01-14 | English | ||
|
2025
4 filings
| |||||
| 13362205 | CURRENT REPORT | 2025-11-25 | English | ||
| 13362204 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 13362206 | Director's Dealing 2025 | 2025-10-24 | English | ||
| 13362208 | CURRENT REPORT | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
OSR Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OSR Holdings, Inc. (id: 35169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.